Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 53 results:
Συντάκτης Τίτλος [ Τύπος(Desc)] Έτος
Φίλτρα: Keyword is Gene Expression Regulation, Neoplastic  [Clear All Filters]
Journal Article
Pentheroudakis, G., Mavroeidis L., Papadopoulou K., Koliou G-A., Bamia C., Chatzopoulos K., et al. (2019).  Angiogenic and Antiangiogenic VEGFA Splice Variants in Colorectal Cancer: Prospective Retrospective Cohort Study in Patients Treated With Irinotecan-Based Chemotherapy and Bevacizumab.. Clin Colorectal Cancer. 18(4), e370-e384.
Psyrri, A., Kalogeras K. T., Wirtz R. M., Kouvatseas G., Karayannopoulou G., Goussia A., et al. (2017).  Association of osteopontin with specific prognostic factors and survival in adjuvant breast cancer trials of the Hellenic Cooperative Oncology Group.. J Transl Med. 15(1), 30.
Tripsianis, G., Papadopoulou E., Anagnostopoulos K., Botaitis S., Katotomichelakis M., Romanidis K., et al. (2014).  Coexpression of IL-6 and TNF-α: prognostic significance on breast cancer outcome.. Neoplasma. 61(2), 205-12.
Pectasides, E., Rampias T., Kountourakis P., Sasaki C., Kowalski D., Fountzilas G., et al. (2011).  Comparative prognostic value of epidermal growth factor quantitative protein expression compared with FISH for head and neck squamous cell carcinoma.. Clin Cancer Res. 17(9), 2947-54.
Antoniades, V., Sioga A., Dietrich E. M., Meditskou S., Ekonomou L., & Antoniades K. (2013).  Is copper chelation an effective anti-angiogenic strategy for cancer treatment?. Med Hypotheses. 81(6), 1159-63.
Taliouri, E., Vrekoussis T., Vergetaki A., Agorastos T., & Makrigiannakis A. (2013).  Corticotropin-releasing hormone (CRH) is expressed in the human cervical carcinoma cells (HeLa) and upregulates the expression of Fas ligand.. Tumour Biol. 34(1), 125-30.
Pavlidis, E. T., & Pavlidis T. E. (2018).  Current Molecular and Genetic Aspects of Pancreatic Cancer, the Role of Metastasis Associated Proteins (MTA): A Review.. J Invest Surg. 31(1), 54-66.
Sakai, M., Martinez-Arguelles D. B., Aprikian A. G., Magliocco A. M., & Papadopoulos V. (2016).  De novo steroid biosynthesis in human prostate cell lines and biopsies.. Prostate. 76(6), 575-87.
Mountzios, G., Aivazi D., Kostopoulos I., Kourea H. P., Kouvatseas G., Timotheadou E., et al. (2014).  Differential expression of the insulin-like growth factor receptor among early breast cancer subtypes.. PLoS One. 9(3), e91407.
Ellina, M-I., Bouris P., Aletras A. J., Theocharis A. D., Kletsas D., & Karamanos N. K. (2014).  EGFR and HER2 exert distinct roles on colon cancer cell functional properties and expression of matrix macromolecules.. Biochim Biophys Acta. 1840(8), 2651-61.
Razis, E., Pentheroudakis G., Rigakos G., Bobos M., Kouvatseas G., Tzaida O., et al. (2014).  EGFR gene gain and PTEN protein expression are favorable prognostic factors in patients with KRAS wild-type metastatic colorectal cancer treated with cetuximab.. J Cancer Res Clin Oncol. 140(5), 737-48.
Mitsiades, C. S., Kotoula V., Poulaki V., Sozopoulos E., Negri J., Charalambous E., et al. (2006).  Epidermal growth factor receptor as a therapeutic target in human thyroid carcinoma: mutational and functional analysis.. J Clin Endocrinol Metab. 91(9), 3662-6.
Bouris, P., Skandalis S. S., Piperigkou Z., Afratis N., Karamanou K., Aletras A. J., et al. (2015).  Estrogen receptor alpha mediates epithelial to mesenchymal transition, expression of specific matrix effectors and functional properties of breast cancer cells.. Matrix Biol. 43, 42-60.
Koutras, A., Kalogeras K. T., Wirtz R. M., Alexopoulou Z., Bobos M., Zagouri F., et al. (2015).  Evaluation of the prognostic significance of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) validation study.. J Transl Med. 13, 171.
Korantzis, I., Kalogeras K. T., Papaxoinis G., Kotoula V., Koutras A., Soupos N., et al. (2012).  Expression of angiogenic markers in the peripheral blood of patients with advanced breast cancer treated with weekly docetaxel.. Anticancer Res. 32(10), 4569-80.
Petrakis, G., Kostopoulos I., Venizelos I., Lambropoulou M., Vouras K., Vakalopoulou S., et al. (2017).  Expression of the activation markers Blimp1, Foxp1 and pStat3 in extranodal diffuse large B-cell lymphomas.. Histol Histopathol. 32(8), 825-834.
Pectasides, D., Kotoula V., Papaxoinis G., Alexopoulou Z., Dervenis C., Samantas E., et al. (2016).  Expression Patterns of Growth and Survival Genes with Prognostic Implications in Advanced Pancreatic Cancer.. Anticancer Res. 36(12), 6347-6356.
Papadopoulos, N., Kotini A., Cheva A., Jivannakis T., Manavis J., Alexiadis G., et al. (2002).  Gains and losses of CD8, CD20 and CD56 expression in tumor stroma-infiltrating lymphocytes compared with tumor-associated lymphocytes from ascitic fluid and lymphocytes from tumor draining lymph nodes in serous papillary ovarian carcinoma patients.. Eur J Gynaecol Oncol. 23(6), 533-6.
Mathas, S., Kreher S., Meaburn K. J., Jöhrens K., Lamprecht B., Assaf C., et al. (2009).  Gene deregulation and spatial genome reorganization near breakpoints prior to formation of translocations in anaplastic large cell lymphoma.. Proc Natl Acad Sci U S A. 106(14), 5831-6.
Purrington, K. S., Visscher D. W., Wang C., Yannoukakos D., Hamann U., Nevanlinna H., et al. (2016).  Genes associated with histopathologic features of triple negative breast tumors predict molecular subtypes.. Breast Cancer Res Treat. 157(1), 117-31.
Pentheroudakis, G., Spector Y., Krikelis D., Kotoula V., Meiri E., Malamou-Mitsi V., et al. (2013).  Global microRNA profiling in favorable prognosis subgroups of cancer of unknown primary (CUP) demonstrates no significant expression differences with metastases of matched known primary tumors.. Clin Exp Metastasis. 30(4), 431-9.
Fountzilas, G., Valavanis C., Kotoula V., Eleftheraki A. G., Kalogeras K. T., Tzaida O., et al. (2012).  HER2 and TOP2A in high-risk early breast cancer patients treated with adjuvant epirubicin-based dose-dense sequential chemotherapy.. J Transl Med. 10, 10.
Martin, V., Landi L., Molinari F., Fountzilas G., Geva R., Riva A., et al. (2013).  HER2 gene copy number status may influence clinical efficacy to anti-EGFR monoclonal antibodies in metastatic colorectal cancer patients.. Br J Cancer. 108(3), 668-75.
Pentheroudakis, G., Raptou G., Kotoula V., Wirtz R. M., Vrettou E., Karavasilis V., et al. (2015).  Immune response gene expression in colorectal cancer carries distinct prognostic implications according to tissue, stage and site: a prospective retrospective translational study in the context of a hellenic cooperative oncology group randomised trial.. PLoS One. 10(5), e0124612.
Papaioannou, N., Psalla D., Zavlaris M., Loukopoulos P., Tziris N., & Vlemmas I. (2009).  Immunohistochemical expression of dog TERT in canine testicular tumours in relation to PCNA, ki67 and p53 expression.. Vet Res Commun. 33(8), 905-19.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές